University of Glasgow: Precision Medicine
|Institution||University of Glasgow View institution profile|
|Department||School of Medicine|
|Telephone||0141 330 4515|
**This programme is open for applicants domiciled in Scotland and the European Union**.
This **fully funded tuition fee waiver** programme is awarded by the Universities of Glasgow, Aberdeen and Strathclyde, and in collaboration with the Universities of Dundee and Edinburgh. Students can be based in either Glasgow or Aberdeen.
Stratified Medicine holds huge potential in the timely development of new treatments for human disease. It is among the most important concepts to emerge in 21st century clinical science and will be a crucial component of the global drive to increase the efficacy, safety and cost effectiveness of new treatments. This new taught postgraduate Masters programme draws on the current and future needs of the Life Sciences sector, to create a highly skilled workforce and is being developed in conjunction with the industrial partners of the Stratified Medicine Scotland Innovation Centre (SMS-IC). It harnesses Scotland’s strengths in Stratified Medicine, Clinical Trials, Bioinformatics and Pharmacogenomics to provide focused training which integrates basic and clinical sciences, and equips students with grounding in the essential skills required to design, execute and evaluate modern clinical interventions.
**Academic contact: email@example.com
Admissions enquiries: www.gla.ac.uk/enquirenow
MSc: 12 months full-time**
**WHY THIS PROGRAMME**
Students will be given the unique opportunity to undertake an industry placement as their main project. This fantastic opportunity will be offered by partner commercial organisations/companies and universities.
The programme will cover aspects of commercial innovation and entrepreneurial skills, together with the principles which underpin the emerging science at the interface between genetics and pharmacology.
Students on the programme will undergo theoretical and practical training in state-of-the-art research processes, enabling an appreciation of how to apply novel stratified approaches, together with clinical pharmacological, regulatory and ethical principles to the optimisation of future clinical research and therapeutic practice.
Students will also gain an understanding of statistical methods used to evaluate the efficacy and cost-effectiveness of new treatments, and direct experience of how all of these techniques are applied by academic and industrial researchers in the development of new medicines.
Following successful completion of the programme a joint master’s degree will be awarded.
The five stakeholder universities, Glasgow, Aberdeen, Strathclyde, Dundee and Edinburgh are internationally recognised as leaders in biomedical research, hosting highly collaborative and productive groups with the requisite expertise in pharmacology, clinical trial methodology, pharmacogenomics, and life sciences. This vibrant environment, coupled with Scotland’s tradition of excellence in clinical research and significant recent investment in the new science of Stratified Medicine make it the ideal place to acquire the transferrable skills required for a successful and fulfilling career in 21st century biomedicine.
This MSc degree is awarded jointly by the Universities of Glasgow, Aberdeen and Strathclyde. Courses included in this programme are delivered by these three institutions as well as the Universities of Dundee and Edinburgh. Students will be offered a choice of base institution, either Glasgow or Aberdeen. Each base campus has its own programme structure; however students from both campuses will study courses covering three themes totalling 120 credits.
For the most up to date information on the courses available at each campus please contact:
**Programme alteration or discontinuation**
The University of Glasgow endeavours to run all programmes as advertised. For more information, please see: Student contract.
|Level||SCQF Level 11|
Candidates must normally possess:
Dissertation and presentation.
This MSc degree is awarded jointly by the Universities of Glasgow, Aberdeen and Strathclyde. Courses included in this programme are delivered by these three institutions as well as the Universities of Dundee and Edinburgh. Students will be offered a choice of base institution, either Glasgow or Aberdeen. Each base campus has its own programme structure; however students from both campuses will study courses covering three themes totalling 120 credits. Sample course are included below. For the most up to date information on the courses available at each campus please contact firstname.lastname@example.org
Scientific basis of stratified medicine:
Commercialisation of science:
Application of research and evaluation of new technologies:
Project and Assessment:
|Location||University of Glasgow|
University of Glasgow
|EU||8000 GBP for Year 1|
|Scotland||8000 GBP for Year 1|
|England||8000 GBP for Year 1|
|Wales||8000 GBP for Year 1|
|Northern Ireland||8000 GBP for Year 1|
University of Glasgow
Ask a question: Enquire now
The University of Glasgow is one of the UK’s most prestigious seats of learning, and the fourth oldest university in the English speaking world. Established in 1451 and recognised for its world-changing research and teaching, the University has inspired thinkers from eminent scientist Lord Kelvin and the father of economics Adam Smith, to Scotland’s First Minister Nicola Sturgeon.
- ranked joint 69th in the world and was the first UK university to be rated as 5 Stars Plus overall (QS World University Rankings 2019)
- ranked joint 93rd in the ...
Not what you are looking for?Browse other courses in Medicine (general and para-medical) or Pharmacology, or search our comprehensive database of postgrad programs.
Scholarship Opportunity with Postgrad.com
Are you a PG student at this University or have you applied to study a postgraduate program at a university in Europe? Tell us your plans and qualify for a £500.00 PGS Scholarship.Click here